Tyrosine kinase inhibitor therapies for gastrointestinal stromal tumours

To assess the effectiveness and the toxicity of targeted therapy for the treatment of GISTs.

This is a protocol.

Health topics:

Cancer > Stomach

Gastroenterology & hepatology > Cancer: other gastrointestinal

Published:

15 February 2018

Authors:

Mocellin S, Pasquali S, Campana L, Yuan Y, Gronchi A, Griffiths E, Vohra R

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Mocellin S, Pasquali S, Campana L, Yuan Y, Gronchi A, Griffiths E, Vohra R. Tyrosine kinase inhibitor therapies for gastrointestinal stromal tumours. Cochrane Database of Systematic Reviews 2018, Issue 2. Art. No.: CD012951. DOI: 10.1002/14651858.CD012951